Mary L. Schapiro - 21 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: Director
Signature: /s/ Mary L. Schapiro
Issuer symbol: CVS
Transactions as of: 21 Nov 2024
Net transactions value: +$167,500
Form type: 4
Filing time: 25 Nov 2024, 17:53:55 UTC
Previous filing: 03 Jun 2024
Next filing: 03 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVS	Common Stock						11,844	21 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Deferred Stock Units	Award	$167,500	+2,933	+14%	$57.10	24,437	21 Nov 2024	Common Stock	2,933	$0.000000	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2	Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.